文献速递膀胱癌与上尿路尿路上皮癌

机器人辅助根治性膀胱切除术后健康相关生活质量的恢复

Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
PubMed 文献 · BJU Int · 2021-07-05

该研究报告了机器人辅助根治性膀胱切除联合体内尿流改道(iRARC)后健康相关生活质量(HRQoL)的恢复情况。纳入2016年1月至2017年12月连续接受iRARC且随访至少12个月的患者76例,完成EORTC-QLQ-C30和EORTC-QLQ-BLM30问卷。多数功能领域和症状在6个月内恢复或超过基线,但回肠 conduit(IC)患者躯体功能至12个月仍低于基线;总体HRQoL两组均保持稳定,术后并发症是总体HRQoL恶化的主要驱动因素;性功能在iRARC后显著受损,结构化的性功能康复应成为根治性膀胱切除术路径的组成部分。

要点

  • iRARC后多数功能领域和症状在6个月内恢复或超过基线。
  • 回肠 conduit 患者躯体功能至12个月仍低于基线。
  • 术后并发症是总体HRQoL恶化的主要预测因素。

核心结论

  • 大多数功能领域和症状量表在iRARC后6个月内恢复至或超过基线水平。
  • 回肠 conduit 患者躯体功能至12个月仍低于基线。
  • 两种尿流改道类型的总体HRQoL均得以保持,但术后并发症似乎是总体HRQoL的主要驱动因素。
  • iRARC后性功能受到不良影响,提示结构化的性功能康复应成为根治性膀胱切除术路径的组成部分。

研究设计与样本

  • 连续纳入2016年1月至2017年12月接受iRARC的患者,术前完成EORTC-QLQ-C30和EORTC-QLQ-BLM30问卷,术后至少随访12个月。
  • 共76例患者符合12个月纳入标准,其中新膀胱(NB)24例,回肠 conduit(IC)52例。

主要发现

  • NB组较IC组更年轻(57.0 vs 71.0岁,P < 0.001)且更健康,基线躯体功能(100.0 vs 93.3,P = 0.039)和性功能(66.7 vs 50.0,P = 0.013)评分更高。
  • 术后3个月,两组躯体功能(NB: 93.3 vs 100.0,P = 0.020;IC: 80.0 vs 93.3,P < 0.001)和角色功能(NB: 83.3 vs 100.0,P = 0.010;IC: 83.3 vs 100.0,P = 0.017)下降,疲乏评分(NB: 22.2 vs 11.1,P = 0.026;IC: 33.3 vs 22.2,P = 0.008)升高。
  • 除IC组躯体功能至12个月仍低于基线(86.7 vs 93.3,P = 0.012)外,其余评分在6个月时恢复至基线。
  • 两组总体HRQoL评分术后无显著变化;90天Clavien-Dindo重大并发症是3个月总体HRQoL恶化的显著预测因素(OR 0.11,95% CI 0.02-0.62;P = 0.012),晚期并发症是12个月总体HRQoL恶化的预测因素(OR 0.14,95% CI 0.03-0.65;P = 0.013)。
  • EORTC-QLQ-BLM30显示,3个月时泌尿问题(NB: 14.3 vs 38.3,P < 0.001;IC: 5.6 vs 19.1,P < 0.001)和未来展望(NB: 33.3 vs 44.4,P = 0.004;IC: 22.2 vs 44.4,P < 0.001)评分优于基线;性功能在3个月显著下降(NB: 8.3 vs 66.7,P < 0.001;IC: 4.2 vs 50.0,P < 0.001),12个月改善但仍低于基线(NB: 33.3 vs 66.7,P = 0.001;IC: 25.0 vs 50.0,P < 0.001);参与阴茎康复是12个月性功能评分更高的显著预测因素(β 18.62,95% CI 6.06-30.45;P = 0.005)。

临床怎么用

  • iRARC后应关注患者HRQoL恢复,尤其IC患者躯体功能可能持续低于基线至12个月。
  • 术后并发症是总体HRQoL恶化的主要驱动因素,应积极预防和管理并发症。
  • 性功能康复应整合进根治性膀胱切除术路径,阴茎康复参与与更好的12个月性功能相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the health-related quality of life (HRQoL) after robot-assisted radical cystectomy and intracorporeal urinary diversion (iRARC), and to identify factors impacting on return to baseline. PATIENTS AND METHODS: Consecutive patients undergoing iRARC between January 2016 and December 2017 completed the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire 30-item core (EORTC-QLQ-C30) and EORTC-QLQ-Muscle-Invasive Bladder Cancer Module (EORTC-QLQ-BLM30) questionnaires before surgery and had a minimum of 12 months follow-up postoperatively. RESULTS: A total of 76 patients met the inclusion criteria at 12 months. Neobladder (NB) cases (n = 24) were younger (57.0 vs 71.0 years, P < 0.001) and fitter than ileal conduit (IC) cases (n = 52), and had higher physical (100.0 vs 93.3, P = 0.039) and sexual functioning (66.7 vs 50.0, P = 0.013) scores at baseline. Longitudinal analysis of the EORTC-QLQ-C30 showed that physical (NB: 93.3 vs 100.0, P = 0.020; IC: 80.0 vs 93.3, P < 0.001) and role functioning scores (NB: 83.3 vs 100.0, P = 0.010; IC: 83.3 vs 100.0, P = 0.017) decreased and fatigue score (NB: 22.2 vs 11.1, P = 0.026; IC: 33.3 vs 22.2, P = 0.008) increased at 3 months in both diversion groups. Scores returned to baseline at 6 months except physical functioning score in IC patients that remained below baseline until 12 months (86.7 vs 93.3, P = 0.012). The global HRQoL score did not show significant change postoperatively in both groups. A major 90-day Clavien-Dindo complication was a significant predictor (odds ratio [OR] 0.11, 95% confidence interval [CI] 0.02-0.62; P = 0.012) of deteriorated global HRQoL score at 3 months, while occurrence of a late complication (OR 0.14, 95% CI 0.03-0.65; P = 0.013) was a predictor of deteriorated global HRQoL score at 12 months. Longitudinal analysis of the EORTC-QLQ-BLM30 showed that urinary problems (NB: 14.3 vs 38.3, P < 0.001; IC: 5.6 vs 19.1, P < 0.001) and future perspective (NB: 33.3 vs 44.4, P = 0.004; IC: 22.2 vs 44.4, P < 0.001) scores were better than baseline at 3 months. Sexual function deteriorated significantly at 3 months (NB: 8.3 vs 66.7, P < 0.001; IC: 4.2 vs 50.0, P < 0.001) and then showed improvement at 12 months but was still below baseline (NB: 33.3 vs 66.7, P = 0.001; IC: 25.0 vs 50.0, P < 0.001). Involvement in penile rehabilitation was shown to be a significant predictor (β 18.62, 95% CI 6.06-30.45; P = 0.005) of higher sexual function score at 12 months. CONCLUSION: While most functional domains and symptoms scales recover to or exceed baseline within 6 months of iRARC, physical function remains below baseline in IC patients up to 12 months. Global HRQoL is preserved for both types of urinary diversion; however, postoperative complications seem to be the main driving factor for global HRQoL. Sexual function is adversely affected after iRARC suggesting that structured rehabilitation of sexual function should be an integral part of the RC pathway.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Abozaid M, Tan WS, Khetrapal P, et al. Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion. BJU Int. 2021. PMID: 34092021. doi:10.1111/bju.15505

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。